0001571049-16-011760.txt : 20160212 0001571049-16-011760.hdr.sgml : 20160212 20160212210106 ACCESSION NUMBER: 0001571049-16-011760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160210 FILED AS OF DATE: 20160212 DATE AS OF CHANGE: 20160212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENDHEIM JACK CENTRAL INDEX KEY: 0001241560 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 161422295 MAIL ADDRESS: STREET 1: C/O EMPIRE RESOURCES, INC. STREET 2: 1 PARKER PLAZA, SUIET 10 CITY: FORT LEE STATE: NJ ZIP: 07024 4 1 t160413_x1.xml OWNERSHIP DOCUMENT X0306 4 2016-02-10 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001241560 BENDHEIM JACK 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 1 1 1 0 President and CEO Class A Common Stock 2016-02-10 4 C 0 12000 A 78000 I See Class A Common Stock 2016-02-10 4 S 0 3400 30.78 D 74600 I See Class B Common Stock 2016-02-10 4 C 0 12000 D Class A Common Stock 12000 20887811 I See The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date. The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC on March 16, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.04 to $31.18, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for Jack C. Bendheim 2016-02-12